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Abstract
Background: Around a quarter of the world’s neonatal and maternal deaths occur in India. Morbidity and
mortality are highest in rural areas and among the poorest wealth quintiles. Few interventions to improve maternal
and newborn health outcomes with government-mandated community health workers have been rigorously
evaluated at scale in this setting.
The study aims to assess the impact of a community mobilisation intervention with women’s groups facilitated by
ASHAs to improve maternal and newborn health outcomes among rural tribal communities of Jharkhand and
Orissa.
Methods/design: The study is a cluster-randomised controlled trial and will be implemented in five districts, three
in Jharkhand and two in Orissa. The unit of randomisation is a rural cluster of approximately 5000 population. We
identified villages within rural, tribal areas of five districts, approached them for participation in the study and
enrolled them into 30 clusters, with approximately 10 ASHAs per cluster. Within each district, 6 clusters were
randomly allocated to receive the community intervention or to the control group, resulting in 15 intervention and
15 control clusters. Randomisation was carried out in the presence of local stakeholders who selected the cluster
numbers and allocated them to intervention or control using a pre-generated random number sequence. The
intervention is a participatory learning and action cycle where ASHAs support community women’s groups
through a four-phase process in which they identify and prioritise local maternal and newborn health problems,
implement strategies to address these and evaluate the result. The cycle is designed to fit with the ASHAs’
mandate to mobilise communities for health and to complement their other tasks, including increasing
institutional delivery rates and providing home visits to mothers and newborns. The trial’s primary endpoint is
neonatal mortality during 24 months of intervention. Additional endpoints include home care practices and health
care-seeking in the antenatal, delivery and postnatal period. The impact of the intervention will be measured
through a prospective surveillance system implemented by the project team, through which mothers will be
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interviewed around six weeks after delivery. Cost data and qualitative data are collected for cost-effectiveness and
process evaluations.
Study registration: ISRCTN: ISRCTN31567106
Background and rationale
Millennium development goals 4 and 5
Little time is left to achieve Millennium Development
Goals (MDGs) 4 and 5 for maternal and child survival.
Only 19 of 68 priority countries are on track to achieve
MDG4, which calls for a two-thirds reduction in under-
five mortality rates from 1990 levels [1]. Because neona-
tal deaths account for 41% of under-5 deaths, achieving
MDG 4 requires scaling up strategies to reduce neonatal
mortality [2]. Effective interventions have long been
identified, and key questions now concern the best ways
to increase their coverage in an equitable manner, parti-
cularly in countries and communities with high mortal-
ity rates [3-5].
Maternal and child survival in India
Around a quarter of the world’s neonatal and maternal
deaths occur in India [6]. The current neonatal mortal-
ity rate (NMR) is estimated at 34.3 per 1000 live births
[7] and the maternal mortality ratio at 254 per 100 000
live births [8]. The child mortality rate declined from
33.5 (24.1-45.4) deaths per 1000 live births in 1990 to
13.6 (9.0-19.7) in 2010, and the maternal mortality ratio
from 523 (310-835) to 254 (154-395) between 1990 and
2008 [7,8]. To meet MDG4 however, an accelerated
reduction in neonatal mortality is required as neonatal
deaths account for 55% of under-five deaths [1]. Neona-
tal mortality rates vary widely between states, ranging
from 11 in Kerala to 48 in Uttar Pradesh [9]. They also
vary within states and between social groups: the NMR
in rural areas is about one and a half times that of
urban areas, and rates among the poorest wealth quin-
tile are more than double those among the richest [10].
Socio-economically disadvantaged communities such as
indigenous or adivasi groups (defined in India’s demo-
graphic surveys as Scheduled Tribes) have particularly
high mortality rates: adivasi children have a 25%
increased risk of dying before the age of five compared
to non-adivasi children [11].
Current maternal and child health government
programmes in India
The Government of India implements three large inter-
secting programmes to improve women and children’s
health. The first is the Reproductive and Child Health II
(2005-10) programme, which includes the Integrated
Management of Newborn and Childhood Illnesses
(IMNCI) at community and facility-levels, promotion of
skilled care at birth, Essential Newborn Care training for
professionals, and health service strengthening. The sec-
ond is the Integrated Child Development Services
(ICDS) programme, which provides a range of nutrition
interventions for women and children. The third is
India’s flagship National Rural Health Mission pro-
gramme (2005-2012), including the Janani Suraksha
Yojana (JSY) maternity incentive scheme under which
all pregnant women living below the poverty line receive
money to deliver in a health facility and receive postna-
tal check-ups [12]. The NRHM also finances an esti-
mated 820,000 community health volunteers called
Accredited Social Health Activists (ASHAs) in priority
states. ASHAs are mandated to disseminate health infor-
mation, counsel women on issues of reproductive and
child health and provide essential supplies and drugs (e.
g Oral Rehydration Salts and antimalarials). The ASHA
programme provides an important platform for scaling
up effective community-based interventions for maternal
and newborn survival [13].
Community-based interventions to improve newborn
survival
Several community-based interventions have demon-
strated substantial effects on neonatal mortality [14,15].
In the home-based newborn care model developed by
SEARCH Gadchiroli [16] a trained community health
worker identified pregnant women, conducted group
health education, carried out two antenatal and 8-12
postnatal home visits, attended deliveries, gave infants a
vitamin K injection, identified and managed high risk
infants who had signs of sepsis by providing injectable
antibiotics in the home and encouraged appropriate
referral. This intervention led to a 70% reduction in
neonatal mortality over 10 years of incremental imple-
mentation, was replicated with seven NGOs (Ankur
study) covering around 80 000 population. Elements
from home-based newborn care and home visits have
been incorporated into ASHAs’ training. Following this
and other studies, WHO and UNICEF endorsed home
visits with components of home-based newborn care as
a strategy to improve newborn survival in low-resource
settings [17,18]. There is now a need for operational
research to examine the feasibility of scaling up this
strategy, with equity as a prime concern [19].
Other models emphasise the importance of commu-
nity mobilisation and participation to improve maternal
and newborn health, either with or without a concurrent
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programme of home-based newborn care. These inter-
ventions are premised on the notion that many maternal
and newborn deaths can be avoided through better
understanding of health problems, changes in antenatal
and newborn care practices, and improvements in com-
munity perceptions of, and demand for, health services.
Several community mobilisation interventions have used
a participatory approach, building on the idea that if
mothers and other community members take part in
decision-making and bring local knowledge, experiences
and problems to the fore, they are more likely to own
and sustain solutions to improve their communities’
health [20]. The Shivgarh trial in Uttar Pradesh success-
fully tested a combined approach of home visits with
social mobilisation through community change agents,
leading to a 54% (RR: 0.46, 95%CI: 0.35-0.60) reduction
in neonatal mortality over 15 months [21]. The Mak-
wanpur and Ekjut trials showed reductions of 30% (OR:
0.70, 95% CI 0.53-0.94) and 45% (OR: 0.55, 95%CI: 0.46-
0.66) in neonatal mortality through community mobili-
sation with women’s groups [22,23], but it remains
unclear whether this impact could be maintained if
implemented at scale using existing community health
workers or volunteers as women’s group facilitators.
In India, the NRHM has called for both an expansion
of ASHAs’ training in home-based newborn care and
for “constituting community-based women empower-
ment groups [...] with the aim to ensure that the female
functionaries - ASHAs, Anganwadi workers and Auxili-
ary Nurse Midwives–become accountable to and work
with these groups to help them realise their well-being
and rights.” [23] Community mobilisation for health is
part of the mandate of ASHAs, but specific strategies
for community mobilisation led by these workers have
yet to be tested [24].
Justification for this study
Although several intervention models have shown
impacts on neonatal survival in India, we do not know
whether any of these can bring improvements when
delivered through government-linked community health
workers such as ASHAs, nor what the barriers and facil-
itators to scale up might be. This trial aims to test
whether a proven participatory community intervention
with women’s groups can improve maternal and new-
born health when implemented with ASHAs, examine
its interaction with home visits for maternal and new-
born care, and identify the processes through which the
intervention can be successfully delivered and scaled-up.
Although the women’s group intervention has already
been tested in three trials, we decided to adopt a clus-
ter-randomised controlled design to evaluate its impact
with ASHAs for two reasons. First, the community
mobilisation intervention has not been tested when
delivered by community health workers (CHWs); other
programmes combining community mobilisation with
essential newborn care and delivered by CHWs were
not evaluated with baseline data or a control group [25].
Second, several NRHM interventions (including home
visits and JSY) are being implemented in the study areas
and only an RCT would allow us to robustly quantify
the contribution of community mobilisation to any mor-
tality reduction in this context.
In addition, the study is needed to address key imple-
mentation research questions and identify strategies for
scaling up. Taking community health worker pro-
grammes to scale raises questions about adequate levels
of remuneration, training, supervision and motivation.
Providing recommendations to address these is critical:
in a 2007 study, only 3-12% of children born at home in
5 south Asian and sub-Saharan African countries
received a visit from a trained health worker within 3
days of birth [26]. Implementation research is necessary
in order to understand how best to implement the inter-
vention with ASHAs and whether community mobilisa-
tion will supplement or impede their existing activities.
Design and methods
Study design
The study is a cluster-randomised controlled trial. Clus-
ter randomisation was preferred over individual rando-
mization as the intervention is a community
mobilisation programme delivered at a village-level and
with the potential to influence health outcomes both
within and between households. An implementation
research component is carried out through the trial’s
process evaluation.
Aim
To assess the impact and scalability of a community
mobilisation intervention with women’s groups facili-
tated by ASHAs to improve maternal and newborn
health outcomes among rural tribal communities of
Jharkhand and Orissa
Objectives
1. To test the impact of a community mobilisation inter-
vention with women’s groups led by ASHAs on:
(a) Birth outcomes, including neonatal mortality and
stillbirths
(b) Care practices and health care-seeking behaviour
for mothers and newborns
2. To examine the contribution of community mobili-
sation with women’s groups to maternal and newborn
health outcomes in the context of other government
programmes
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3. To document the context, delivery and costs of the
intervention in order to identify lessons for scale-up
Primary research question
What is the effect of a community mobilisation inter-
vention led by ASHAs on neonatal and perinatal mortal-
ity rates?
Secondary research questions
What is the effect of the intervention on home care
practices and health-care seeking behaviour?
What are the factors to consider in scaling up of this
intervention, if successful?
Trial endpoints
The trial’s primary endpoint is the neonatal mortality
rate over 24 months. Because we expect a short lag per-
iod for this intervention to take effect as groups take
some time to discuss the causes of maternal and new-
born health problems before implementing strategies,
we will include data for the last 24 months of the study
(1st January 2011 - 31st December 2012) in the final ana-
lysis for the primary endpoint, thereby allowing for a
four month lag-period. Additional endpoints for the trial
include home care practices and health-care seeking
behaviour for mothers and newborns and ASHAs’ activ-
ities related to home visits. The trial endpoints are listed
in Table 1.
Selection of clusters and unit of randomisation
The trial area covers a population of approximately
158,053 (based on 2001 Indian Census data) in three
districts of Jharkhand (Ranchi, Khunti and Godda) and
two districts of Orissa (Mayurbhanj and Rayagada). The
location of study areas is shown in Figure 1 and district
characteristics in Table 2. The unit of randomisation is
a rural geographic cluster of approximately 5000 popula-
tion. Within each district, the intervention team mapped
villages and formed 6 clusters constituted of 5-8 villages
and their neighbouring hamlets, with at least 10 active
ASHAs per cluster. Within each district, 6 clusters were
randomly allocated to receive the community interven-
tion or to the control group, as described in Figure 2.
Intervention and control clusters are separated either by
natural boundaries (rivers or hills), or by ‘buffer villages’
not enrolled in the trial.
Setting
The study takes place in two districts of Orissa and
three districts of Jharkhand, two states of eastern India.
The five districts are largely rural and have a high pro-
portion of adivasi people. The main tribal groups in the
trial area are the Ho, Munda, Oraon, Santhal, Binjhiya,
Paharia, Bhumij, Bhatudi, Bhuyian, Gond, Mankidia and
Kondh. In previously published research carried out in
other rural tribal areas of these states, [22] we found a
neonatal mortality rate of 58 per 1000 livebirths and a
maternal mortality ratio of 510 per 100 000 livebirths.
Around 35% of mothers had three or more antenatal
check-ups and only 17% delivered in a health facility. In
December 2010, the recruitment of ASHAs had been
completed in Jharkhand and Orissa but their training in
home-based newborn care had not begun. JSY was oper-
ating in both states but had higher coverage in Orissa
[13]. The trial is being implemented by Ekjut, an NGO
that has been working in Jharkhand and Orissa since
2003, in collaboration with the Centre for International
Health and Development at University College London
(UK).
Target group and eligibility criteria
The target population will be rural, mainly tribal com-
munities with poor access to health services. The target
group for the women’s group intervention is women of
childbearing age between the ages of 15 and 49 years,
and particularly pregnant mothers. However the groups
are open to all community members, including adoles-
cent girls, older women and men. Community health
workers may also participate in group discussions. Parti-
cipants in the trial will be all women who have given
birth in the study area between 1st September 2009 and
31st of August 2010 for the baseline period, and between
01st of September 2010 and 31st December 2012 for the
trial period, and who have agreed to take part in the
study when approached by an interviewer around six
weeks after delivery. Excluded are women who decline
to be interviewed or have migrated out of the study
clusters, and, for secondary outcomes (care-seeking and
home care practices), women who gave birth in the
study area but who cannot be traced after 9 months.
During an earlier trial, 1.3% of births detected by a simi-
lar surveillance system to the one used in this study
(255 out of 19068) were to mothers who migrated in or
out of the study clusters, and we were not able to obtain
background socio-economic data on these migrants. The
intention to treat population (for the primary outcome)
will therefore be all mothers who reside in the study
clusters and have given birth in the study area in the
last 24 months of the intervention and did not migrate
out of the study clusters. Participation in intervention
activities will be voluntary and women are free to join
or leave a group at any time.
Randomisation and allocation
The randomisation was carried out as follows: in each
district, we invited stakeholders from each cluster,
including Village Health Committee members and staff
from other NGOs to a meeting. We allocated a number
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to each cluster, wrote these numbers on small plastic
balls and placed the balls within a dark bag. The inter-
vention team reminded stakeholders about the aim and
length of the intervention and about the purpose of the
randomization process. We asked each of the partici-
pants to draw one ball from the bag and read the cluster
number out until all balls had been picked. The num-
bers were then written on a sheet of paper in the order
of selection. Finally we placed twenty pieces of paper
numbered 1 to 20 - each corresponding to a unique
allocation sequence generated by CP in Excel - in the
dark bag and asked a participant to select a paper and
read out the number. The corresponding sequence was
then used to publicly allocate each cluster to one of two
groups to ensure transparency among the stakeholders
and also to avoid conflict as only intervention area
ASHAs would be entitled to incentives.
The interventions
Women’s groups The intervention is a participatory
learning and action cycle of 20 meetings, during which
women’s groups open to other community members
identify and prioritise maternal and newborn health
Table 1 Trial outcomes and indicators
Mortality
Neonatal mortality rate Number of Neonatal deaths per 1000 livebirths
Stillbirth rate Number of Stillbirths per 1000 births
Early neonatal mortality rate Number of early neonatal deaths (0-6 days) per 1000 livebirths
Late neonatal mortality rate Number of late neonatal deaths (7-28 days) per 1000 livebirths
Maternal mortality ratio Number of maternal deaths per 100 000 livebirths
Pregnancy-related mortality ratio Number of pregnancy-related deaths per 100 000 livebirths
Perinatal mortality rate Number of perinatal deaths per 1000 births
Care-seeking practices
4+ ANC visits % of births for which mothers received 3+ ANC visits from a skilled provider (doctor, ANM, or other nurse)
Care-seeking for a problem in
pregnancy
% of births for which mother had a problem in pregnancy and sought care from a qualified provider
Institutional delivery % of births that took place at health facility (public or private)
Birth preparedness % of births for which mothers who made a plan for the delivery
Skilled Birth Attendance % of home births for which mothers delivered with a skilled birth attendant (doctor, ANM, or other nurse)
Care-seeking for delivery
complications
% of births in which complications were identified for which mother sought skilled care
Maternal postnatal visit (qualified
provider)
% of births for which mother received at least one postnatal check-up from skilled provider (doctor, ANM or
other nurse)
Infant postnatal visits (qualified
provider)
% of births for which child received at least one postnatal check-up from skilled provider (doctor, ANM, other
nurse or ASHA)
Care-seeking for infant illness % of births for which mothers sought care from qualified provider if infant had either fever, diarrhoea or
cough in first 6 weeks
Home care practices
Clean delivery practices For home births only:
% of births for which attendant washed their hands with soap
% of births for which attendant/mother had a sheet
% of births for which attendant had new or boiled blade
% of births for which attendant boiled thread
% of births for which attendant washed their hands
% of births for which attendant put nothing/antiseptic on cord
Immediate and exclusive
breastfeeding
% of liveborn infants breastfed within first hour
% of liveborn infants exclusively breastfed for first six weeks
Thermal care % of liveborn infants wrapped within first hour after birth
% of liveborn infants wiped within first hour after birth
% of liveborn infants not bathed in first 24 hours after birth
Skin-to-skin/kangaroo care % of liveborn infants given kangaroo (skin to skin care) within the first hour after birth
Interaction with other interventions
Home visits & JSY % mothers who received home visits on the 1st day of life
% mothers who received home visits on 1st, 3rd and 7th day of life
% mothers who had an institutional delivery assisted by the Janani Suraksha Yojana scheme
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problems in their area, identify strategies to address
these, implement these strategies and evaluate the entire
process. This cycle was adapted from an earlier inter-
vention tested during the Ekjut trial and in other set-
tings [27,28]. Specific adaptations based on lessons from
the Ekjut trial included a minimum recruitment of preg-
nant women into groups and an emphasis on care for
newborns during winter, as a strong increase in neonatal
deaths was observed in the study areas during this sea-
son. The team also prioritized materials to be used (e.g.
picture cards) by selecting the most important maternal
and newborn problems with ASHAs. The cycle con-
sisted of fortnightly meetings for the first four months
(Phase 1 and Phase 2), following by monthly meetings
after this, as described in Table 3. In the first phase,
consisting of three meetings, the ASHA will introduce
the project, then help the group identify and prioritise
local maternal and newborn health problems. In the
second phase, consisting of four meetings, groups dis-
cuss causes and solutions to prioritized problems
through participatory games and using picture cards,
then identify and prioritise strategies for addressing the
problems. At the end of this phase the groups prepare
to hold a community meeting in which they share their
thoughts, problems and strategies with other community
members, including men, traditional birth attendants,
mothers-in-law and Community Health Workers. In
phase three, the groups implement their strategies and
carry out practical role-plays focusing on care-seeking
and emergencies. Finally, in phase four the groups eval-
uate each of the phases and progress on their prioritized
strategies. The intervention is expected to run for 24
months (20 meetings, two community meetings and two
additional months to make up for any cancellations of
meetings).
ASHA selection, training and incentivisation In each
district we approached district-level ASHA coordinators
and Village Health Committees (VHCs), explained the
women’s group intervention and asked VHCs to identify
suitable ASHAs to facilitate the groups. These ASHAs
had to be functional according to government criteria:
they needed to have undergone at least three training
sessions and be village-based. We identified problems
that could arise whilst working with ASHAs during the
course of the intervention and agreed on strategies to
address these. In order to assist the ASHAs, we
appointed a co-facilitator who was given an incentive of
Rs 50 per meeting to help with record keeping. This co-
facilitator was not given training to conduct meetings,
and ASHAs were left in charge of facilitation. Should an
ASHA not be accepted by her village, we agreed that
the district-based intervention team would seek to help
her, and, if unsuccessful, ask the co-facilitator to con-
duct meetings after training. In the event that an ASHA
should drop out of the intervention permanently the
VHC and women’s group would decide whether a new
ASHA should be trained, or whether a co-facilitator
should take over and be paid the full incentive. The
intervention team designed four training sessions for
Figure 1 Study area.
Table 2 Study area characteristics
District Population* ASHAs (n) Villages (n)
Ranchi 31,135 104 35
Godda 29,097 42 41
Rayagada 34,144 56 99
Mayurbhanj 31,913 50 52
Khunti 31,764 66 71
Total 158,053 318 298
* 2009 projection from 2001 Indian Census
Figure 2 Trial design.
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selected ASHAs, one for each phase of the intervention.
One cluster coordinator employed by Ekjut is posted in
each district. ASHAs are given an incentive of Rs100
per day as in government trainings (US$2) and Rs200
per meeting. A total of 149 ASHAs were selected to
implement the intervention.
Additional interventions Community involvement in
monitoring health services is an essential component of
the NRHM programme. Village health and sanitation
committees (VHSCs or VHCs) are mandated to monitor
local services as well as disseminate information about
rights and entitlements to healthcare. We will undertake
three main activities related to strengthening health ser-
vices in both intervention and control areas. First, we
will carry out at least one village health committee
meeting about rights and entitlements in each village
during the study period. Second, we will organise meet-
ings with government officials and hospital management
Table 3 Intervention meeting plan
ASHA TRAINING 1
Phase I:
Problems
Meeting
1
Introduction to the project
Meeting
2
Identifying & prioritizing maternal problems in the community
Meeting
3
Identifying & prioritizing neonatal problems in the community
ASHA TRAINING 2
Phase II:
Strategies
Meeting
4
Thermal care for newborns (story on preventing winter deaths)
Meeting
5
Understanding causes and solutions for prioritized problems (story focusing on causes, effects and management)
Meeting
6
Identifying and prioritising strategies for implementation
Meeting
7
Choosing a method & preparing for sharing at the community meeting
Meeting
8
Preparing for a community meeting
COMMUNITY MEETING 1 AND ASHA TRAINING 3
Phase III:
Implementation
Meeting
9
Assigning responsibilities for the implementation of strategies
Meeting
10
Birth preparedness - Hygienic practices - Essential Newborn Care - Management of twins and low birth weight babies
(demonstration)
Meeting
11
Understanding & implementing home care strategies using picture cards
Meeting
12
Understanding & implementing preventive strategies using picture cards
Meeting
13
Understanding & implementing strategies for newborn emergency problems using picture cards
ASHA TRAINING 4
Meeting
14
Accessing appropriate care (game)
Meeting
15
Emergency preparedness for maternal and neonatal problems (role-play)
Meeting
16
Preventing maternal deaths through campaigning against the first delay
Meeting
17
Learning about strategies implemented by other groups
Meeting
18
Preparation for community meeting
COMMUNITY MEETING 2
ASHA TRAINING 5
Phase IV: Meeting
19
Phase-wise evaluation
Evaluation Meeting
20
Evaluation of women’s group activities
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committees to inform the provision of appropriate care
for mothers and newborns in facilities in the study dis-
tricts. Finally, we will carry out at least one meeting
with ASHAs using the appreciative inquiry method [29]
to strengthen their job motivation and help them further
enhance their work performance.
Impact evaluation
Sample size A sample size calculation was carried out
in June 2010 using 11 months of available data on birth
outcomes from the study areas prior to the creation of
clusters. Baseline mortality data collected from the study
areas between 1st February 2009 and 31st December
2009 indicated an NMR of 66 per 1000. We estimated k
(the between cluster correlation coefficient) at 0.1 on
the basis of data from the Ekjut trial as well as baseline
data from the JOHAR trial areas. On the basis of sur-
veillance from existing clusters, for an average cluster
population of 5000, we expect an estimated 100 live-
births per cluster per year. We aim to assess the impact
of the intervention using a total of 2 years of birth out-
comes. We used formulae from Hayes and Bennett to
estimate the power of the study [30]. Assuming a more
conservative baseline mortality rate estimate of 55 per
1000, with 100 livebirths per cluster per year in 30 clus-
ters, the study will have between 76.6% and 79.6%
power to detect a 30% reduction in the NMR (from 55
per 1000 to 38.5 per 1000) over 24 months.
Surveillance A monitoring team independent from the
intervention team was established to collect information
on births and deaths to women of reproductive age and
on events during the antenatal, delivery and postnatal
periods through a surveillance system adapted from a
previous study, covering a total population of around
158,053 [31] and described in Figure 3. One key infor-
mant (a community member) reports all births and
deaths to women of reproductive age to an interviewer.
The informant is visited on a monthly basis by an inter-
viewer from the surveillance team. The interviewer
checks the report, pays the informant an incentive of
Rs30 for an identification and another Rs 50 for con-
ducting an interview with the identified mother around
six weeks after the delivery. The collected questionnaires
are examined by District Monitoring Coordinators with
guidance from District Managers. Completed question-
naires are then entered into a database designed in
Microsoft Access. Baseline data on birth outcomes were
collected for a full year from 1st September 2009 to 31st
August 2010.
Data monitoring, masking and analysis plan Due to
the nature of the intervention, the intervention team or
participants cannot be blinded to the allocation however
the analysts will be blinded to the allocation for the data
safety and monitoring board and until the definitive
analysis is performed. The intervention and monitoring
team hold their meetings on separate days, and the con-
tent of the intervention is not discussed with monitoring
team members. We shall analyse data for the primary
and secondary endpoints for a data safety and monitor-
ing board (DSMB) to be held in late 2011. The DSMB
will be undertaken according to the principles stated in
the DAMOCLES statement [32]. We will carry out
intention-to-treat analyses using individual level data,
adjusting for clustering using either logistic regression
with random effects or generalised estimating equations
[33]. In this data safety and monitoring board we will
analyse data for the period from 1st September 2010 till
31st June 2011 (10 months of data). The DSMB will
have three objectives:
(1) To report on the observed number of livebirths
and neonatal mortality rate in the trial area in order
to examine whether the original sample size calcula-
tion is robust; if the expected number of livebirths
has not been reached the DSMB may recommend
extending the trial;
(2) To assess the comparability of trial arms by
examining data on the socio-economic characteris-
tics of participants and clusters at baseline, including
the coverage of home visits, in order to define any
adjustments to be made in the final analysis;
(3) To examine available data for the primary and
secondary endpoints in order to decide whether to
continue or stop the trial
Stopping rules Because previous trials of women’s
groups in Nepal and eastern India have shown a strong
effect of groups on neonatal mortality, we aim to stop
the trial and introduce groups into the control area after
the DSMB if we observe a reduction in the NMR of
40% or more after adjusting for differences observed at
baseline, or if we observe a reduction inferior to 40%
but with improvements in secondary indicators (home
care or care seeking practices) consistent with a reduc-
tion, and satisfactory implementation quality indicators
(70% or more of ASHAs have conducted all meetings at
Figure 3 Trial vital events surveillance system.
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the time of the DSMB; % of women who gave birth in
the study area who received information from a group
member; % of women of reproductive age in group
meetings).
Sub-analyses We will compare the proportion of
women who received postnatal home visits by an ASHA
and the proportion of women who delivered in institu-
tions among areas with and without ASHA-led
mobilisation.
Process evaluation
The process evaluation has five objectives:
1. To describe the context in which the intervention
was delivered (including the backdrop of NRHM
interventions in intervention and control)
2. To describe the intervention in theory (model)
and in practice (the way in which it was delivered)
3. To identify factors that facilitate or prevent the
delivery of this intervention by ASHAs, and its
implementation at scale
4. To develop hypotheses about the mechanisms
through which the intervention may have worked,
including its interaction with NRHM interventions
5. To compare the mechanisms linked to the success
of the NGO facilitator-led intervention with those of
the ASHA-led intervention
Methods We will use a mix of quantitative and qualita-
tive methods to address each of these objectives, as
described in Table 4. The process evaluation will aim to
identify factors that would facilitate scale up.
Data management
Quantitative data will be entered in the main office in a
relational database on Microsoft Access. All infants
born in the study clusters will be given a unique ID.
After checking and entry the questionnaires will be
stored in a locked room for future reference. Qualitative
data will be collected either in note form or audio-
recorded. Audio-recordings will be kept on a dedicated,
password protected computer by the process evaluation
manager. Qualitative focus group discussions and inter-
views will be transcribed and analysed using a thematic
approach.
Quality control
One key informant per 250 population will identify
births and to women of reproductive age. Each event
will be checked by an interviewer, who will pay the key
informant an incentive. Surveillance monitors will meet
regularly with interviewers both in the field and at the
district offices. Accuracy of the quantitative data will be
checked first by the interviewer, then by the Monitoring
coordinators and District Managers and finally at the
time of data entry in the main office. Data cleaning will
be carried out internally through systematic checks on
key fields (mother ID, baby ID, birth outcome).
Strategies to reduce contamination
Contamination may occur if ASHAs or women discuss
issues related to maternal and newborn health with each
other between clusters. This may happen if ASHAs tra-
vel from one cluster to another (for example for training
or to meet relatives), or if participants migrate perma-
nently or temporarily to a neighbouring cluster. This
may result in information or strategies being shared, the
effect of the intervention spreading to control clusters
and dilution of differences between treatment arms. In
order to reduce the risk of contamination, intervention
and control clusters are separated either by natural
boundaries (e.g. hills or rivers) or by ‘buffer villages’. In
the five rural districts where the study will take place,
villages are quite distant from each other. We will also
ask about exposure to women’s groups in control areas
so will be able to quantify any contamination.
Economic evaluation
All intervention related costs, including start-up and
running costs will be audited through the project
accounting system. We shall carry out a cost-effective-
ness analysis to determine the scalability of the interven-
tion and their replicability within existing government
systems. We will also estimate the cost per neonatal
death averted.
Ethical issues
Community consent We shall seek permission from
local community representatives (headmen in Jharkhand
and Panchayati Raj institution leaders in Orissa) to
work with women’s groups and the ASHAs, and to col-
lect data in their areas. These representatives were
invited to the public randomisation.
Individual consent Individual consent will be sought
from each mother approached as a result of a birth or
death identification, and consent recorded through a sig-
nature or thumbprint.
Benefits to the control communities Because the
women’s group intervention has demonstrated an
impact on neonatal mortality in a similar setting, we
have put in place stopping rules in order to introduce
the intervention to control areas if positive results are
observed at the first data safety and monitoring board.
In addition, activities such as strengthening of Village
Health Committees and Appreciative Inquiry workshops
with ASHAs will be conducted in both intervention and
control clusters.
Treatment of illness in participating communities
The study team will encourage referral to an appropriate
health facility if they identify minor, acute or chronic ill-
ness in mothers or infants in either intervention or con-
trol areas.
Confidentiality of information All information will be
confidential. Access to information will be limited to
interviewers and monitors in the field and main office
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Table 4 Process evaluation objectives, methods and data sources
OBJECTIVE INDICATORS & ISSUES METHODS DATA SOURCE
1. To describe the context in which the intervention was delivered
Information on terrain, infrastructure and
health service provision
Discussions with facilitators, NGO and
government staff
Quantitative analysis of formats
Context notes and formats
M&E data*
Meeting reporting formats collated by
co-facilitators
HSS mapping format
Process evaluation manager notes
Profile of intervention and control
communities, cultural practices including
health practices, livelihoods including seasonal
occupation, and migration
Quantitative analysis
Qualitative analysis of discussions with ASHAs
and observation notes of project staff
M&E data (including baseline data)
Context format
Process evaluation manager notes
Profile of clusters
(Population composition, number of ASHAs,
population size and spread of ASHA
catchment area, number of villages, hamlets
and total population)
Quantitative analysis M&E data
Population Census, 2001
Context format
Objective 2: to describe the intervention in theory and in practice
Intervention plan Trial protocol
Profile of ASHAs
category, n of training modules completed)
Profile of co-facilitators
Profile of cluster coordinators
Quantitative analysis ASHA profile register
Cluster coordinator reports
ASHA profile register
ASHA and cluster coordinator recruitment
process and training
Qualitative review of recruitment process of
cluster coordinator and co-facilitators
Qualitative summary of training reports
Interview schedules and process
evaluation manager notes
District-level training reports (6 × 5),
training schedule, materials and games
ASHAs’, cluster coordinators’ and co-facilitators’
perception of the intervention
Qualitative analysis Discussion with ASHAs and cluster
coordinators at the end of each
intervention phase
Discussions with co-facilitators by
cluster coordinators at the end of the
cycle
Meeting site Quantitative compilation Discussion with ASHAs and cluster
coordinators at the end of each
intervention phase
Group characteristics Quantitative analysis Group description format held by
cluster coordinators (name, location, n
of meetings, month/year of formation)
Meeting duration, attendance, member
characteristics & group discontinuation
Quantitative analysis Meeting reporting format
Process evaluation manager notes of
review meetings with cluster
coordinators (for HR issues with ASHAs
and co-facilitators)
District-level HR register for cluster
coordinators, ASHAs & co-facilitators
M&E data
Identification and prioritization of problems Quantitative analysis Prioritised problem format (meeting
specific)
Women’s group observation notes (5
groups followed from start to end of
cycle)
Identification and prioritization of strategies Quantitative analysis Strategies format (meeting specific)
M&E data
Village-level and cluster-level community
meetings
(ASHAs’ and cluster coordinators’ perception)
Qualitative summary Discussion with ASHAs and cluster
coordinators at the end of each
intervention phase (1-4)
Community meeting format (use for 1st
and 2nd community meetings)
Support given to members for community
meetings
Methods for obtaining and using resources for
the community meetings
Qualitative summary Review meeting notes
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and then to data entry management staff. No publica-
tions, analyses or reports will include the names of
participants.
Sustainability and scalability One key objective of the
study is to identify mechanisms for scaling up the inter-
vention. We will share implementation plans and find-
ings with NRHM implementers in Jharkhand and
Orissa. The intervention will be introduced immediately
into the control areas if a positive impact is observed at
the first Data Safety and Monitoring board. We shall
invite a representative of the Indian Council of Medical
Research to join the data safety monitoring group.
Approval Ethical approval for the study is being sought
through an independent ethical research committee
chaired by Dr AK Debdas in Jamshedpur, India. The
study was approved by the Research Ethics Committee
of University College London (UK) with project identifi-
cation number 1488/001.
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Table 4 Process evaluation objectives, methods and data sources (Continued)
Members’ phase-wise evaluation of
intervention
Quantitative analysis Phase-wise evaluation chart
Group members’ perception of the
intervention and its impact
Qualitative analysis of 10 focus group
discussions with group members (2 per
district)
FGD transcripts
Objective 3: To identify factors that facilitate or prevent the delivery of this intervention by ASHAs and its implementation at scale
Enablers and barriers to ASHAs delivering the
intervention
Qualitative analysis of 5 FGDs (1 per district)
at the end of the PLA cycle and women’s
group case studies
Qualitative summary
FGD transcripts and case study notes
Reports of ASHAs, coordinators and
cluster coordinator
HR lessons for scaling-up Qualitative summary Costing formats (Rajesh Sinha)
Notes from review meetings with
ASHAs and coordinators
Objective 4: To develop hypotheses about the mechanisms through which the intervention may have worked
Group discussion with Ekjut team members
to review the process evaluation findings
and generate a list of hypotheses about the
intervention mechanisms
FGD transcripts
Quantitative analyses
Case studies notes
Observation notes
Facilitators’ registers
Objective 5: To compare the mechanisms linked to the success of the facilitator-led intervention with those of the ASHA-led intervention
Perception of group members regarding
behaviour change among themselves and
non-group members
5 group discussions with group members FGD transcripts
Case studies
Population coverage of groups & coverage of
pregnant women as compared with Ekjut trial
intervention
Census data
Register
M&E
Coordinators’ and cluster coordinators’
perceptions of intervention mechanisms
Discussion incorporating results of FGDs with
group members to obtain coordinators’
feedback
Discussion notes
Workload analysis of facilitators in ASHAs in
JOHAR trial
Qualitative summary Documents from review meetings with
ASHAs
* M&E refers to the main trial monitoring and evaluation questionnaire
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